Vela Investment Management, LLC Biomarin Pharmaceutical Inc Transaction History

Vela Investment Management, LLC

  • $317 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 08, 2023
BUY
$86.68 - $100.3 $90,320 - $104,512
1,042 Added 22.94%
5,584 $484,000
Q1 2023

May 08, 2023
BUY
$87.74 - $117.27 $92,127 - $123,133
1,050 Added 30.07%
4,542 $441,000
Q3 2022

Nov 10, 2022
BUY
$82.16 - $96.94 $286,902 - $338,514
3,492 New
3,492 $296,000

Others Institutions Holding BMRN

# of Institutions
637
Shares Held
177M
Call Options Held
2.01M
Put Options Held
1.28M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.5B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Vela Investment Management, LLC Portfolio

Follow Vela Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vela Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vela Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email